57 related articles for article (PubMed ID: 5992828)
1. The assessment of total body iron stores using the chelating agent diethylene-triamine penta-acetic acid (D.T.P.A.). Its significance for human haemochromatosis.
Powell LW
Rev Med Chir Mal Foie; 1966 Dec; 41(6):271-80. PubMed ID: 5992828
[No Abstract] [Full Text] [Related]
2. Use of diethylenetriamine penta-acetic acid (D.T.P.A.) in the clinical assessment of total body iron stores.
Powell LW; Thomas MJ
J Clin Pathol; 1967 Nov; 20(6):896-904. PubMed ID: 5614075
[TBL] [Abstract][Full Text] [Related]
3. IDIOPATHIC HAEMOCHROMATOSIS IN MENSTRUATING WOMEN. A FAMILY STUDY, INCLUDING THE USE OF DIETHYLENE TRIAMINE PENTA-ACETIC ACID.
LLOYD HM; POWELL LW; THOMAS MJ
Lancet; 1964 Sep; 2(7359):555-7. PubMed ID: 14172348
[No Abstract] [Full Text] [Related]
4. [DESFERRIOXAMINE (DF) AND DIETHYLENE TRIAMINE PENTA-ACETIC ACID TRISODIUM CALCIUM SALT (CA DTPA NA3) IN SIDEROSIS. 2].
ALBAHARY C
Presse Med (1893); 1965 Jan; 73():73-6. PubMed ID: 14234334
[No Abstract] [Full Text] [Related]
5. Measurement of iron stores in cirrhosis using diethylenetriamine penta-acetic acid.
Barry M; Cartei G; Sherlock S
Gut; 1970 Nov; 11(11):899-904. PubMed ID: 5492247
[TBL] [Abstract][Full Text] [Related]
6. Quantitative measurement of iron stores with diethylenetriamine penta-acetic acid.
Barry M; Cartei G; Sherlock S
Gut; 1970 Nov; 11(11):891-8. PubMed ID: 5492246
[TBL] [Abstract][Full Text] [Related]
7. THE NEW CHELATING AGENT CA-DTPA IN THE TREATMENT OF PRIMARY HAEMOCHROMATOSIS.
KEMBLE JV
Guys Hosp Rep; 1964; 113():68-73. PubMed ID: 14114732
[No Abstract] [Full Text] [Related]
8. Hepatic iron concentration in hereditary hemochromatosis does not saturate or accurately predict phlebotomy requirements.
Olynyk JK; Luxon BA; Britton RS; Bacon BR
Am J Gastroenterol; 1998 Mar; 93(3):346-50. PubMed ID: 9517637
[TBL] [Abstract][Full Text] [Related]
9. Two-year clinical follow-up results of intracoronary radiation therapy with rhenium-188-diethylene triamine penta-acetic acid-filled balloon.
Cho YS; Kim MA; Hwang KK; Koo BK; Oh S; Chae IH; Kim HS; Lee DS; Oh BH; Lee MM; Park YB; Choi YS
Catheter Cardiovasc Interv; 2004 Nov; 63(3):274-81. PubMed ID: 15505867
[TBL] [Abstract][Full Text] [Related]
10. Diethylene-triamine-penta-acetate administration protocol for radiological emergency medicine in nuclear fuel reprocessing plants.
Jin Y
Hemoglobin; 2008; 32(1-2):199-206. PubMed ID: 18274997
[TBL] [Abstract][Full Text] [Related]
11. THE USE OF DTPA IN THE DIAGNOSIS AND MANAGEMENT OF IDIOPATHIC HAEMOCHROMATOSIS.
WALSH RJ; PERKINS KW; BLACKBURN CR; SANFORD R; CANTRILL S
Australas Ann Med; 1963 Aug; 12():192-6. PubMed ID: 14058164
[No Abstract] [Full Text] [Related]
12. [Hemochromatoses].
Bonardi R
Minerva Med; 1978 Jan; 69(4):279-82. PubMed ID: 415262
[No Abstract] [Full Text] [Related]
13. A simple, highly sensitive and improved method for the measurement of bleomycin-detectable iron: the 'catalytic iron index' and its value in the assessment of iron status in haemochromatosis.
Burkitt MJ; Milne L; Raafat A
Clin Sci (Lond); 2001 Mar; 100(3):239-47. PubMed ID: 11222109
[TBL] [Abstract][Full Text] [Related]
14. Detecting genetic haemochromatosis.
Dooley JS; Walker AP
Practitioner; 2007 May; 251(1694):82, 84, 86 passim. PubMed ID: 17564138
[No Abstract] [Full Text] [Related]
15. Plasma ferritin concentrations: their clinical significance and relevance to patient care.
Valberg LS
Can Med Assoc J; 1980 Jun; 122(11):1240-8. PubMed ID: 6992966
[TBL] [Abstract][Full Text] [Related]
16. The CD8+ T-lymphocyte profile as a modifier of iron overload in HFE hemochromatosis: an update of clinical and immunological data from 70 C282Y homozygous subjects.
Cruz E; Melo G; Lacerda R; Almeida S; Porto G
Blood Cells Mol Dis; 2006; 37(1):33-9. PubMed ID: 16762569
[TBL] [Abstract][Full Text] [Related]
17. Diabetes and haemochromatosis: current concepts, management and prevention.
Yaouanq JM
Diabete Metab; 1995 Dec; 21(5):319-29. PubMed ID: 8586148
[TBL] [Abstract][Full Text] [Related]
18. [Adiastole caused by a secondary cardiac hemochromatosis. Successful treatment with an iron chelating agent].
Baudouy P; Lombrail P; Azancot I; Piekarski A; Martin E; Slama R
Arch Mal Coeur Vaiss; 1983 Oct; 76(10):1240-6. PubMed ID: 6418103
[TBL] [Abstract][Full Text] [Related]
19. [Primary hemochromatosis and dietary iron].
Borch-Iohnsen B
Tidsskr Nor Laegeforen; 1997 Oct; 117(24):3506-7. PubMed ID: 9411910
[TBL] [Abstract][Full Text] [Related]
20. Serum iron estimations in the diagnosis of haemochromatosis.
HOUSTON JC; THOMPSON RH
Guys Hosp Rep; 1953; 102(4):355-9. PubMed ID: 13117339
[No Abstract] [Full Text] [Related]
[Next] [New Search]
